Skip to main content
Premium Trial:

Request an Annual Quote

QFAB to Provide Sequence Analysis Services for Garvan Institute

Premium

NEW YORK (GenomeWeb) – QFAB Bioinformatics said this week that it has been selected by Australia's Garvan Institute of Medical Research to provide whole genome sequence analysis services to researchers in Australia and the Asia-Pacific region.

According to the QFAB, the partnership will provide researchers in the scientific and medical community with high-throughput sequencing and analysis services that span experimental design through to variant interpretation. This agreement extends a long-term relationship between the Garvan Institute and QFAB and "offers strong support for our business," Jeremy Barker, QFAB's CEO, said in a statement.

Financial and other terms of the agreement were not disclosed.

Filed under

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.